InsidersTradesSigma
Track the Dr. Reddy's Laboratories Limited share price and the full insider trade history of the company, a listed equity based in India. Shares trade on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Dr. Reddy's Laboratories Limited has logged 406 reports. Market capitalisation: €964.5bn. The latest transaction was disclosed on 27 March 2026 (Purchase). Among the most active insiders: Dr. Reddy's Employees ESOS Trust. All data is free.
406
Insider Decl.
n/a
Thresholds
€33m
241 ops.
Buy Volume
€28m
164 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Dr. Reddy's Laboratories Limited Hold (neutral), based on 40 analysts. Average price target: ₹1,336.30.
15Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,028 of 29,064 companies
59.2
score / 100
Value50
Quality68
FCF yld1.8%
Earn yld4.3%
EV/EBITDA13.6x
ROE8.8%
Gross mgn53%
Net mgn13%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 27 March 2026
Declarations406 total
3,675 shares@ ₹1,301.89990.0000% mcap42.1% of flowADR/GDR/FCCBSEBI:45230f24a84db46cc8b14b0c281a1f563076d1ee
4,275 shares@ ₹1,267.150214.0% of flowEquity SharesSEBI:822ca6b2345cf2621e60ff9466315e91affff923
4,775 shares@ ₹1,316.40100.0% of flowADR/GDR/FCCBSEBI:12397999a46a73696eb8b2cb38851e7b5df97759
10,495 shares@ ₹1,260.8011.8% of flowADR/GDR/FCCBSEBI:71816ffee125b52204b6af171b43c9529dd5ef46
7,450 shares@ ₹1,292.1012.8% of flowADR/GDR/FCCBSEBI:86d33db5422baec141b37128c053b753ec5e9f42
7,450 shares@ ₹1,291.60100.0% of flowADR/GDR/FCCBSEBI:9a07849b7fe719b923089f65397e5e5162acfe70
8,440 shares@ ₹1,325.4511.2% of flowEquity SharesSEBI:ca7e09c9c591c0642ad41a1868cf98765813d196
1,495 shares@ ₹1,325.450211.1% of flowEquity SharesSEBI:c774b42f99bc9c9c69c9dcdc47e081bdb5446006
1,250 shares@ ₹1,361.4504100.0% of flowEquity SharesSEBI:cbffd07a0456fe2014a1947757b32d1f55eba36d
2,050 shares@ ₹1,361.45372.6% of flowEquity SharesSEBI:e7334e232c6c933eee2cf3cd4dfa11e5da1224c6
1,670 shares@ ₹1,361.45036.2% of flowEquity SharesSEBI:e9ac179127cc280090adf9a413cd47f5985d558b
1,412 shares@ ₹6,553.009.1% of flowADR/GDR/FCCBSEBI:14339ac2b99aa3e6de215c668612c78ee42b8ce8
1,594 shares@ ₹6,553.0063.6% of flowADR/GDR/FCCBSEBI:c792667a8e4f2aa03d7372d7e23b406ecdcaee9e
1,700 shares@ ₹6,651.413516.2% of flowADR/GDR/FCCBSEBI:485a090766fc1d5ae19b33ab176e9078af181b69
150 shares@ ₹6,914.0047.6% of flowADR/GDR/FCCBSEBI:98fb5c592eeec2578963d0b26554f66fbdd3c543
704 shares@ ₹6,914.0075.3% of flowADR/GDR/FCCBSEBI:b3e7e26b4f07a30cedee660c5ff6d5bbcdb58dc0
145 shares@ ₹6,914.0033.1% of flowADR/GDR/FCCBSEBI:6fa92ed9233363a2096a34f71bebddd2f15c6897
215 shares@ ₹6,914.0036.8% of flowADR/GDR/FCCBSEBI:b2a590e11b6e5f7bb729fc2e02c09600b6647802
1,250 shares@ ₹6,914.724812.4% of flowADR/GDR/FCCBSEBI:67ec9ba677b0f9f575bd752fa42dd722f5bce9ea
474 shares@ ₹6,914.0019.8% of flowADR/GDR/FCCBSEBI:dd58cd6759927e0612b21c8b7723db23a8dc4704
594 shares@ ₹6,802.777811.8% of flowADR/GDR/FCCBSEBI:7ca38455e4ae5753d0bed2779c66d7c4221db444
814 shares@ ₹6,914.006.1% of flowADR/GDR/FCCBSEBI:242380ba5867de3db5bc86037cc0fc97b993c2ec
27,635 shares@ ₹16,134.78213.6% of flowADR/GDR/FCCBSEBI:5bd736ed73b8ad889442291f8e6dce5e6285d684
65,500 shares@ ₹6,711.42613.6% of flowADR/GDR/FCCBSEBI:684be7024ba26d6180e0e5b111479e0c0404c6ba
625 shares@ ₹6,095.10085.7% of flowADR/GDR/FCCBSEBI:d2cb053c5c71d12be79b2aa234dd5992cd94263a
25 of 406 declarations
关于 Dr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories Limited 是一家印度制药公司，开发、制造和销售各种仿制药、品牌药和生物制剂。该公司在孟买证券交易所上市。